207 related articles for article (PubMed ID: 9564885)
1. P53- and CD95-associated apoptosis in neurodegenerative diseases.
de la Monte SM; Sohn YK; Ganju N; Wands JR
Lab Invest; 1998 Apr; 78(4):401-11. PubMed ID: 9564885
[TBL] [Abstract][Full Text] [Related]
2. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
Waldmeier PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
[TBL] [Abstract][Full Text] [Related]
3. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
[TBL] [Abstract][Full Text] [Related]
8. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
9. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
Sheard MA; Uldrijan S; Vojtesek B
Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
11. [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases].
Wang L; Zhu M; Li X; Gui Q
Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):120-3. PubMed ID: 11940310
[TBL] [Abstract][Full Text] [Related]
12. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
de la Monte SM; Sohn YK; Wands JR
J Neurol Sci; 1997 Nov; 152(1):73-83. PubMed ID: 9395128
[TBL] [Abstract][Full Text] [Related]
13. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis.
Martin LJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):613-22. PubMed ID: 11114260
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
Sebeo J; Hof PR; Perl DP
Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
[TBL] [Abstract][Full Text] [Related]
15. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
17. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
19. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
Rezaie P; Pontikis CC; Hudson L; Cairns NJ; Lantos PL
J Histochem Cytochem; 2005 Aug; 53(8):929-40. PubMed ID: 16055747
[TBL] [Abstract][Full Text] [Related]
20. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]